Guillaume Cardouat
Pessac-sur-dordogne, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
CXCR4 Blockade Alleviates Pulmonary and Cardiac Outcomes in Early Chronic Obstructive Pulmonary Disease.
Journal: American journal of respiratory cell and molecular biology
Published: April 08, 2025
Celastrol has beneficial effects on pulmonary hypertension associated with bronchopulmonary dysplasia: Preclinical study outcomes.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 07, 2024
NGF increases Connexin-43 expression and function in pulmonary arterial smooth muscle cells to induce pulmonary artery hyperreactivity.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 26, 2023
OP2113, a new drug for chronic hypoxia-induced pulmonary hypertension treatment in rat.
Journal: British journal of pharmacology
Published: November 15, 2022
Cell Confluence Modulates TRPV4 Channel Activity in Response to Hypoxia.
Journal: Biomolecules
Published: May 13, 2022
Muscarinic receptor M3 activation promotes fibrocytes contraction.
Journal: Frontiers in pharmacology
Published: May 09, 2022
NiONP-Induced Oxidative Stress and Mitochondrial Impairment in an In Vitro Pulmonary Vascular Cell Model Mimicking Endothelial Dysfunction.
Journal: Antioxidants (Basel, Switzerland)
Published: April 06, 2022
Involvement of the Piezo1 and TRPV4 stretch-activated channels in pulmonary hypertension
Journal: Revue des maladies respiratoires
Published: January 05, 2022
Last Updated: 09/26/2026